United States Human Vaccine Market Report 2016

Name: United States Human Vaccine Market Report 2016
Brand: QYResearch
SKU: U66AC89A534EN
Price: 3800 USD
Availability: InStock

October 2016 | 113 pages | ID: U66AC89A534EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

Notes:

Sales, means the sales volume of Human Vaccine

Revenue, means the sales value of Human Vaccine

This report studies sales (consumption) of Human Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

GSK
Merck
Novartis
Pfizer
Sanofi
AstraZeneca
Johnson & Johnson
Bavarian Nordic
CSL
Emergent Biosolutions
Unilab
China National Biotec Group
Hualan Bio
Zhifei
Sinovac
Walvax
Liaoning Chengda
Neptunus Group

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Pediatric
Adult vaccine
Type III

Split by applications, this report focuses on sales, market share and growth rate of Human Vaccine in each application, can be divided into

Application 1
Application 2
Application 3

United States Human Vaccine Market Report 2016

1 HUMAN VACCINE OVERVIEW

1.1 Product Overview and Scope of Human Vaccine
1.2 Classification of Human Vaccine
  1.2.1 Pediatric
  1.2.2 Adult vaccine
  1.2.3 Type III
1.3 Application of Human Vaccine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Human Vaccine (2011-2021)
  1.4.1 United States Human Vaccine Sales and Growth Rate (2011-2021)
  1.4.2 United States Human Vaccine Revenue and Growth Rate (2011-2021)

2 UNITED STATES HUMAN VACCINE COMPETITION BY MANUFACTURERS

2.1 United States Human Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Human Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Human Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Human Vaccine Market Competitive Situation and Trends
  2.4.1 Human Vaccine Market Concentration Rate
  2.4.2 Human Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HUMAN VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Human Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States Human Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States Human Vaccine Price by Type (2011-2016)
3.4 United States Human Vaccine Sales Growth Rate by Type (2011-2016)

4 UNITED STATES HUMAN VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Human Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States Human Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES HUMAN VACCINE MANUFACTURERS PROFILES/ANALYSIS

5.1 GSK
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Human Vaccine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GSK Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck
  5.2.2 Human Vaccine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Novartis
  5.3.2 Human Vaccine Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Novartis Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Pfizer
  5.4.2 Human Vaccine Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Pfizer Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi
  5.5.2 Human Vaccine Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 AstraZeneca
  5.6.2 Human Vaccine Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 AstraZeneca Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Johnson & Johnson
  5.7.2 Human Vaccine Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Johnson & Johnson Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bavarian Nordic
  5.8.2 Human Vaccine Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bavarian Nordic Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 CSL
  5.9.2 Human Vaccine Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 CSL Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Emergent Biosolutions
  5.10.2 Human Vaccine Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Emergent Biosolutions Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Unilab
5.12 China National Biotec Group
5.13 Hualan Bio
5.14 Zhifei
5.15 Sinovac
5.16 Walvax
5.17 Liaoning Chengda
5.18 Neptunus Group

6 HUMAN VACCINE MANUFACTURING COST ANALYSIS

6.1 Human Vaccine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Human Vaccine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Human Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Human Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES HUMAN VACCINE MARKET FORECAST (2016-2021)

10.1 United States Human Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States Human Vaccine Sales Forecast by Type (2016-2021)
10.3 United States Human Vaccine Sales Forecast by Application (2016-2021)
10.4 Human Vaccine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Human Vaccine
Table Classification of Human Vaccine
Figure United States Sales Market Share of Human Vaccine by Type in 2015
Figure Pediatric Picture
Figure Adult vaccine Picture
Table Application of Human Vaccine
Figure United States Sales Market Share of Human Vaccine by Application in 2015
Figure United States Human Vaccine Sales and Growth Rate (2011-2021)
Figure United States Human Vaccine Revenue and Growth Rate (2011-2021)
Table United States Human Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Human Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Vaccine Sales Share by Manufacturers
Figure 2016 Human Vaccine Sales Share by Manufacturers
Table United States Human Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Human Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Human Vaccine Revenue Share by Manufacturers
Table 2016 United States Human Vaccine Revenue Share by Manufacturers
Table United States Market Human Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Human Vaccine Average Price of Key Manufacturers in 2015
Figure Human Vaccine Market Share of Top 3 Manufacturers
Figure Human Vaccine Market Share of Top 5 Manufacturers
Table United States Human Vaccine Sales by Type (2011-2016)
Table United States Human Vaccine Sales Share by Type (2011-2016)
Figure United States Human Vaccine Sales Market Share by Type in 2015
Table United States Human Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Human Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Human Vaccine by Type (2011-2016)
Table United States Human Vaccine Price by Type (2011-2016)
Figure United States Human Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Human Vaccine Sales by Application (2011-2016)
Table United States Human Vaccine Sales Market Share by Application (2011-2016)
Figure United States Human Vaccine Sales Market Share by Application in 2015
Table United States Human Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Human Vaccine Sales Growth Rate by Application (2011-2016)
Table GSK Basic Information List
Table GSK Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Human Vaccine Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Human Vaccine Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Human Vaccine Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Human Vaccine Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Human Vaccine Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Human Vaccine Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Human Vaccine Sales Market Share (2011-2016)
Table Bavarian Nordic Basic Information List
Table Bavarian Nordic Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bavarian Nordic Human Vaccine Sales Market Share (2011-2016)
Table CSL Basic Information List
Table CSL Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Human Vaccine Sales Market Share (2011-2016)
Table Emergent Biosolutions Basic Information List
Table Emergent Biosolutions Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Emergent Biosolutions Human Vaccine Sales Market Share (2011-2016)
Table Unilab Basic Information List
Table Unilab Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Unilab Human Vaccine Sales Market Share (2011-2016)
Table China National Biotec Group Basic Information List
Table China National Biotec Group Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table China National Biotec Group Human Vaccine Sales Market Share (2011-2016)
Table Hualan Bio Basic Information List
Table Hualan Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hualan Bio Human Vaccine Sales Market Share (2011-2016)
Table Zhifei Basic Information List
Table Zhifei Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zhifei Human Vaccine Sales Market Share (2011-2016)
Table Sinovac Basic Information List
Table Sinovac Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sinovac Human Vaccine Sales Market Share (2011-2016)
Table Walvax Basic Information List
Table Walvax Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Walvax Human Vaccine Sales Market Share (2011-2016)
Table Liaoning Chengda Basic Information List
Table Liaoning Chengda Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Liaoning Chengda Human Vaccine Sales Market Share (2011-2016)
Table Neptunus Group Basic Information List
Table Neptunus Group Human Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neptunus Group Human Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Vaccine
Figure Manufacturing Process Analysis of Human Vaccine
Figure Human Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Human Vaccine Major Manufacturers in 2015
Table Major Buyers of Human Vaccine
Table Distributors/Traders List
Figure United States Human Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Human Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Human Vaccine Production Forecast by Type (2016-2021)
Table United States Human Vaccine Consumption Forecast by Application (2016-2021)

United States Human Vaccine Market Report 2016

More Publications

Need Help?

Ask a Question

Market Reports